Organic Letters
Letter
their corresponding annulation products were obtained in 37−
81% yields and 92−96% ee. A substrate derived from chrysin22
could also be utilized in this reaction to afford the annulation
product 3s, an analogue of natural product calomelanol C, in
47% yield and 85% ee. However, in all cases, byproduct 4 was
inevitable under the reaction conditions. In order to determine
the absolute configuration of the product, a single-crystal X-ray
analysis of enantiopure 3a was carried out, and the configuration
was determioned to be R.
The enantioenriched products obtained here could undergo
diverse transformations and could be utilized as key intermediates
for highly efficient syntheses of natural products and bioactive
compounds. As depicted in Scheme 2, demethylation of 3a
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the National Basic Research Program of China from
MOST (2016YFA0202900, 2015CB856600), the National
Natural Science Foundation of China (21332009, 21421091),
and the Strategic Priority Research Program of the Chinese
Academy of Sciences (XDB20000000) for generous financial
support. We thank Mr. Can-Can Bao for carrying out a 1 mmol
scale reaction.
REFERENCES
Scheme 2. Transformations of 3a and 3l into Natural
Product and Bioactive Compound
■
(1) (a) Hoult, J. R. S.; Paya, M. Gen. Pharmacol. 1996, 27, 713−722.
(b) Yu, D.; Suzuki, M.; Xie, L.; Morris-Natschke, S. L.; Lee, K. H. Med.
Res. Rev. 2003, 23, 322−345. (c) Thuong, P. T.; Hung, T. M.; Ngoc,
T. M.; Ha, D. T.; Min, B. S.; Kwack, S. J.; Bae, K. Phytother. Res. 2010,
24, 101−106. (d) Gliszczyn
2012, 11, 77−96.
́
ska, A.; Brodelius, P. E. Phytochem. Rev.
(2) (a) Sun, X.; Sneden, A. T. Planta Med. 1999, 65, 671−673.
(b) Ngadjui, B. T.; Kapche, G. W. F.; Tamboue, H.; Abegaz, B. M.;
Connolly, J. D. Phytochemistry 1999, 51, 119−123. (c) Iinuma, M.;
Tanaka, T.; Takenaka, M.; Mizuno, M.; Asai, F. Phytochemistry 1992,
31, 2487−2490. (d) Li, X. M.; Lin, M.; Wang, Y. H.; Liu, X. Planta
Med. 2004, 70, 160−165.
(3) (a) Xu, S.; Shang, M. Y.; Liu, G. X.; Xu, F.; Wang, X.; Shou, C.
C.; Cai, S. Q. Molecules 2013, 18, 5265−5287. (b) Tabanca, N.; Pawar,
R. S.; Ferreira, D.; Marais, J. P.; Khan, S. I.; Joshi, V.; Khan, I. A. Planta
Med. 2007, 73, 1107−1111. (c) Takechi, M.; Tanaka, Y.; Takehara,
M.; Nonaka, G. I.; Nishioka, I. Phytochemistry 1985, 24, 2245−2250.
(d) Sashidhara, K. V.; Singh, S. P.; Singh, S. V.; Srivastava, R. K.;
Srivastava, K.; Saxena, J. K.; Puri, S. K. Eur. J. Med. Chem. 2013, 60,
497−502. (e) Xiong, Q.; Fan, W.; Tezuka, Y.; Adnyana, I. K.;
Stampoulis, P.; Hattori, M.; Namba, T.; Kadota, S. Planta Med. 2000,
66, 127−133.
(4) Huh, J. R.; Englund, E. E.; Wang, H.; Huang, R.; Huang, P.;
Rastinejad, F.; Littman, D. R. ACS Med. Chem. Lett. 2013, 4, 79−84.
(5) (a) Nair, V. Synth. Commun. 1987, 17, 723−727. (b) Lee, J. M.;
Tseng, T. H.; Lee, Y. J. Synthesis 2001, 2001, 2247−2254. (c) Roelens,
F.; Huvaere, K.; Dhooge, W.; Van Cleemput, M.; Comhaire, F.; De
Keukeleire, D. Eur. J. Med. Chem. 2005, 40, 1042−1051. (d) Li, K.;
Foresee, L. N.; Tunge, J. A. J. Org. Chem. 2005, 70, 2881−2883.
(e) Fillion, E.; Dumas, A. M.; Kuropatwa, B. A.; Malhotra, N. R.; Sitler,
T. C. J. Org. Chem. 2006, 71, 409−412. (f) Rodrigues-Santos, C. E.;
Echevarria, A. Tetrahedron Lett. 2007, 48, 4505−4508. (g) Sun, J.;
Ding, W. X.; Hong, X. P.; Zhang, K. Y.; Zou, Y. Chem. Nat. Compd.
2012, 48, 16−22. (h) Niharika, P.; Ramulu, B. V.; Satyanarayana, G.
Org. Biomol. Chem. 2014, 12, 4347−4360.
(>99% ee after recrystallization) by BBr3 in CH2Cl2 gave
naturally occurring compound (R)-3,4-dihydro-4-(4′-hydrox-
yphenyl)-5,7-dihydroxycoumarin (I). This represents the first
enantioselective synthesis and determines its absolute config-
uration as R.2a Ring opening of 3l by piperidine in THF led to
an antidiabetic agent (II).4,23
In conclusion, we have developed an enantioselective
N-heterocyclic carbene-catalyzed annulation of electron-rich
phenols with enals. The NHC generated from triazolium salt F
derived from L-phenylalanine (DHIQ-NHC) was found to be a
highly efficient catalyst, providing 4-aryl-3,4-dihydrocoumarins
in good yields and excellent ee. The utility of this new method
has been demonstrated by the facile transformation of products
into naturally occurring and bioactive compounds. The mild
reaction conditions, ready availability of both starting materials,
and synthetically appealing products make this methodology
attractive in organic synthesis.
(6) Rh-catalyzed asymmetric 1,4-addition: (a) Defieber, C.; Paquin, J.
F.; Serna, S.; Carreira, E. M. Org. Lett. 2004, 6, 3873−3876. (b) Chen,
G.; Tokunaga, N.; Hayashi, T. Org. Lett. 2005, 7, 2285−2288.
(c) Korenaga, T.; Maenishi, R.; Osaki, K.; Sakai, T. Heterocycles 2010,
80, 157−162. (d) Luo, Y.; Carnell, A. J. Angew. Chem., Int. Ed. 2010,
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
49, 2750−2754. (e) Allen, J. C.; Kociok-Kohn, G.; Frost, C. G. Org.
̈
Biomol. Chem. 2012, 10, 32−35. (f) Mino, T.; Miura, K.; Taguchi, H.;
Watanabe, K.; Sakamoto, M. Tetrahedron: Asymmetry 2015, 26, 1065−
1068.
Experimental procedures and characterization data for all
(7) Kim, H.; Yun, J. Adv. Synth. Catal. 2010, 352, 1881−1885.
(8) Li, X.-H.; Fang, P.; Chen, D.; Hou, X.-L. Org. Chem. Front. 2014,
1, 969−973.
X-ray crystallographic data for 3a (CIF)
AUTHOR INFORMATION
Corresponding Author
■
(9) Caruana, L.; Mondatori, M.; Corti, V.; Morales, S.; Mazzanti, A.;
Fochi, M.; Bernardi, L. Chem. - Eur. J. 2015, 21, 6037−6041.
(10) (a) Nishikata, T.; Yamamoto, Y.; Miyaura, N. Adv. Synth. Catal.
2007, 349, 1759−1764. (b) Yue, G.; Lei, K.; Hirao, H.; Zhou, J. S.
Angew. Chem., Int. Ed. 2015, 54, 6531−6635. (c) Ibrahem, I.; Ma, G.;
ORCID
Afewerki, S.; Cor
́
dova, A. Angew. Chem., Int. Ed. 2013, 52, 878−882.
C
Org. Lett. XXXX, XXX, XXX−XXX